TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07115953: Sub-study of SPYRAL AFFIRM: Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT)

Sponsor: Medtronic Vascular · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 130 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$365,200

Rescue Site Savings

+$232,400

Unlock Full NCT07115953 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07115953 Rescue Dossier →